Description

PT-141 (Bremelanotide) is a synthetic peptide developed for advanced research into sexual arousal and neurological function. It acts primarily as a melanocortin receptor agonist, particularly targeting MC3R and MC4R, which are associated with sexual behaviour and central nervous system pathways. Unlike PDE5 inhibitors, PT-141 works through the nervous system rather than the vascular system, making it a unique subject of interest in libido and neuroendocrine research.